US equities |
NVDA $178.67 ▲+0.00% MU $733.15 ▲+0.00% AMD $508.58 ▲+0.00% SNDK $886.51 ▲+0.00% SPCX $142.07 ▲+0.00% TSLA $378.05 ▲+0.00% SKHY $134.38 ▲+0.00% TSM $388.62 ▲+0.00%
FinancialContent
Business Exposures
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
News headline image
Long-term study finds modern hormone replacement therapy not linked to heart disease risk
Via NewMediaWire
Exposures Product Safety
News headline image
Energy drinks, stimulant products linked to cardiac arrest, heart attack in young adults
Via NewMediaWire
Exposures Product Safety
News headline image
1 Reason Compass Pathways Is Worth a Second Look This Month ↗
Via The Motley Fool
Tickers CMPS
Exposures Product Safety
News headline image
3 quality compounders with promising prospects
Via StockStory
Tickers ASX:TWR CVNA DXCM EHC
Exposures Product Safety
News headline image
Playroom Architect Addresses Montessori Labeling and Safety After Recent Toddler Toy Recalls
Via Press Advantage
Topics Product Recall
Tickers AMZN
Exposures Legal Product Safety
Citizens Group Seeks Federal Review of State Court Recall Rulings
Via Press Advantage
Topics Product Recall
Exposures Legal Product Safety
News headline image
All eyes on flag football: Two new Army teams honor 80-year legacy ahead of the sport’s Olympic debut
Via Brandpoint
Topics Product Recall
Exposures Legal Product Safety
News headline image
Sensient (SXT) Q3 2026 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
Tickers SXT
Exposures Financial Product Safety
News headline image
Major FDA Victory; Preservative-Free Ketamine Approved Ahead of November 10 Goal Date as Commercial Launch Opportunity Comes Into Focus for NRx Pharma
Via PRLog
Exposures Product Safety
News headline image
Waiting for Lower Rates Can Cost Homebuyers in the Capital Region More Than It Saves
Via GlobePRwire
Topics Product Recall
Exposures COVID-19 Legal Product Safety
News headline image
5 must-read analyst questions from Repligen’s Q3 earnings call
Via StockStory
Topics Earnings
Tickers RGEN
Exposures Financial Product Safety
News headline image
Zenas BioPharma Eyes Key Lupus and IL-17 Data as Obexelimab FDA Decision Nears ↗
Via MarketBeat
Tickers ARM ZBIO
Exposures Product Safety
News headline image
Exelixis (EXEL) Q3 2026 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings Retirement
Tickers EXEL
Exposures Financial Pension Product Safety
News headline image
NRx Pharmaceuticals Wins FDA Approval for Preservative-Free Ketamine Injection ↗
Via MarketBeat
Tickers NRXP
Exposures Product Safety
SS Innovations International Inc. (NASDAQ: SSII) Demonstrates Long-Distance Robotic Cardiac Surgery at Industry Events
Via Investor Brand Network
Tickers SSII
Exposures Product Safety
BioMedNewsBreaks — Adaptogenics Health Corp. (CSE: ADPT) Gains Industry Relevance as FDA Eases Restrictions on Pharmacy-Compounded Peptides, NBC News Reports
Via Investor Brand Network
Tickers CSE:ADPT
Exposures Product Safety
BioMedNewsBreaks — Adaptogenics Health Corp. (CSE: ADPT) Sees Regulatory Landscape Shift as Federal Policy Permits Compounding of Six Peptides, Reuters Reports
Via Investor Brand Network
Tickers CSE:ADPT
Exposures Product Safety
News headline image
Regeneron (NASDAQ:REGN) surprises with strong Q3 2026, stock soars
Via StockStory
Tickers REGN
Exposures Product Safety
News headline image
Stoke Therapeutics Q3 Earnings Call Highlights ↗
Via MarketBeat
Topics Earnings
Tickers STOK
Exposures Financial Product Safety
News headline image
X4 Pharmaceuticals Targets 2028 Phase III Data for Mavorixafor in Chronic Neutropenia ↗
Via MarketBeat
Tickers XFOR
Exposures Product Safety
News headline image
NovoCure Q3 Earnings Call Highlights ↗
Via MarketBeat
Topics Earnings
Tickers NVCR
Exposures Financial Product Safety
MissionIRNewsBreaks – Regentis Biomaterials Ltd. (NYSE American: RGNT) Highlights Potential of GelrinC Cartilage Repair Technology
Via Investor Brand Network
Tickers RGNT
Exposures Product Safety
BioMedNewsBreaks — Regentis Biomaterials Ltd. (NYSE American: RGNT) Highlights Potential of GelrinC Cartilage Repair Technology
Via Investor Brand Network
Tickers RGNT
Exposures Product Safety
News headline image
What Insmed (INSM) Said on Its Q3 Earnings Call ↗
Via MarketBeat
Topics Earnings
Tickers INSM
Exposures Financial Product Safety
News headline image
Kymera Therapeutics Q3 Earnings Call Highlights ↗
Via MarketBeat
Topics Earnings
Tickers KYMR
Exposures Financial Product Safety
News headline image
Iovance’s Lifileucel Shows 25% Lung Cancer Response Rate, Targets 2027 FDA Filing ↗
Via MarketBeat
Tickers IOVA
Exposures Product Safety
News headline image
Kaplan Fox Alerts Beta Bionics, Inc. (NASDAQ: BBNX) Investors of Substantial Losses to a Securities Class Action - Critical Deadline is November 3, 2026
Via NewMediaWire
Topics Lawsuit
Tickers BBNX
Exposures Financial Legal Product Safety
News headline image
PolyPid Targets 2027 D-PLEX100 Launch, Unveils Diabetic Foot Infection Program ↗
Via MarketBeat
Tickers PYPD
Exposures Product Safety
News headline image
Teladoc Health Q3 Earnings Call Highlights ↗
Via MarketBeat
Topics Earnings Government
Tickers PTON TDOC
Exposures Financial Political Product Safety
News headline image
DBV Technologies (DBVT) Q3 2026 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
Tickers DBVT
Exposures Financial Product Safety
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >